Market cap
₹16 Cr
Revenue (TTM)
₹325 Cr
P/E Ratio
7.6
P/B Ratio
0.3
Div. Yield
0 %
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
16 | 17,481 | 14,949 | 7,213 | 5,643 |
Revenue (₹ Cr) |
325 | 4,204 | 5,013 | 2,990 | 1,307 |
Net Profit (₹ Cr) |
2.10 | 749.11 | 246.10 | 206.88 | 250.86 |
Net Margin (%) |
0.64 | 17.47 | 4.90 | 6.77 | 18.79 |
RoE (%) |
3.98 | 25.77 | 4.30 | 13.32 | 30.36 |
Price to Earnings |
7.59 | 23.49 | 60.74 | 34.86 | 22.50 |
Price-To-Book |
0.34 | 6.61 | 2.53 | 4.75 | 6.29 |
Income Statement (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Operating Revenue
|
325.42 | 4,203.77 | 5,013.20 | 2,990.46 | 1,307.15 |
|
Total Income
|
326.33 | 4,287.37 | 5,025.40 | 3,054.88 | 1,335.24 |
|
Total Expenditure
|
318.24 | 3,184.37 | 4,354.90 | 2,699.17 | 1,008.83 |
|
EBITDA
|
7.18 | 1,019.40 | 658.30 | 291.29 | 298.32 |
|
Depreciation
|
1.03 | 175.62 | 225.00 | 64.56 | 16.76 |
|
EBIT
|
6.15 | 843.78 | 433.30 | 226.73 | 281.55 |
|
Interest
|
4.13 | 17.76 | 133.40 | 4.82 | 1.46 |
|
Other Income
|
0.90 | 83.60 | 12.20 | 64.42 | 28.09 |
|
Exceptional Items
|
-0.17 | -10.15 | -6.60 | 0.00 | 0.00 |
|
Profit before Tax
|
2.75 | 899.47 | 305.50 | 286.33 | 308.18 |
|
Provision for Tax
|
0.65 | 150.36 | 59.40 | 79.45 | 57.32 |
|
Profit after Tax
|
2.10 | 749.11 | 246.10 | 206.88 | 250.86 |
Liabilities (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
56.27 | 2,925.42 | 5,907.70 | 1,517.11 | 897.65 |
|
Minority Interest
|
0.00 | -2.92 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
5.85 | 511.55 | 3,706.90 | 109.94 | 9.68 |
|
Current Liabilities
|
70.42 | 1,049.57 | 737.50 | 496.20 | 161.66 |
|
Total Liabilities
|
147.88 | 3,830.51 | 10,189.90 | 2,911.23 | 945.13 |
Assets (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
12.03 | 2,564.46 | 8,727.80 | 463.28 | 311.24 |
|
Current Assets
|
117.74 | 1,825.13 | 1,469.90 | 1,512.00 | 737.86 |
|
Total Assets
|
147.88 | 3,830.51 | 10,189.90 | 2,911.23 | 945.13 |
|
Total Debt*
|
41.70 | 122.38 | 3,186.40 | 0.00 | 0.00 |
|
Net Current Assets
|
47.33 | 775.56 | 732.40 | 1,015.80 | 576.21 |
|
Contingent Liabilities
|
0.19 | 10.99 | 450.40 | 9.61 | 9.94 |
Cashflow (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
20.71 | 800.53 | 226.40 | 412.13 | 196.92 |
|
Cash Flow from Investing Activities
|
-1.35 | -181.14 | -2,909.90 | -276.95 | -14.45 |
|
Cash from Financing Activities
|
-19.36 | -554.48 | 2,698.40 | -159.77 | -196.49 |
|
Net Cash Inflow / Outflow
|
0.00 | 64.91 | 14.90 | -24.59 | -14.02 |
Ratios
Profitability Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.38 | 29.54 | 4.42 | 30.71 | 31.00 |
|
ROE (%)
|
3.98 | 25.77 | 4.30 | 13.32 | 30.36 |
|
ROA (%)
|
1.53 | 18.37 | 2.43 | 9.75 | 26.22 |
|
EBIT Margin (%)
|
1.89 | 20.07 | 8.64 | 7.58 | 21.54 |
|
Net Margin (%)
|
0.64 | 17.47 | 4.90 | 6.77 | 18.79 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.56 | 13.15 | 73.68 | 4.67 | 27.71 |
|
EBIT Growth (%)
|
-3.10 | 9.30 | 31.66 | -44.91 | 107.87 |
|
Net Profit Growth (%)
|
28.54 | -1.79 | -2.88 | -40.72 | 83.86 |
|
EPS Growth (%)
|
35.75 | -0.03 | -83.32 | -41.16 | 92.33 |
|
Book Value Growth (%)
|
5.02 | 8.50 | 2.72 | 14.81 | 0.78 |
Valuation Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Price / Earnings
|
7.19 | 23.59 | 59.22 | 34.86 | 22.50 |
|
Price / Book Value
|
0.34 | 6.61 | 2.53 | 4.75 | 6.29 |
|
Dividend Yield (%)
|
0.00 | 2.46 | 0.26 | 1.78 | 0.00 |
|
EV/EBITDA
|
8.02 | 16.40 | 27.37 | 21.96 | 17.56 |
|
Market Cap (₹ Cr)
|
15.67 | 17,158.99 | 13,549.79 | 7,237.65 | 4,532.48 |
Solvency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.09 | 0.03 | 0.51 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.74 | 0.04 | 0.03 | -- | -- |
|
Current Ratio
|
1.67 | 1.74 | 1.99 | 3.05 | 4.56 |
|
Quick Ratio
|
0.49 | 1.23 | 0.98 | 2.18 | 4.22 |
|
Interest Coverage
|
1.66 | 51.65 | 3.29 | 60.40 | 211.80 |
Operating Efficiency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.82 | 10.13 | 5.67 | 6.14 | 7.35 |
|
Asset Turnover
|
2.38 | 1.03 | 0.50 | 1.41 | 1.37 |
|
Receivable days
|
48.16 | 38.37 | 32.76 | 25.54 | 23.11 |
|
Inventory Days
|
102.34 | 34.17 | 55.91 | 32.35 | 18.94 |
|
Payable days
|
65.21 | 146.36 | 103.68 | 70.92 | 36.67 |
|
Cash Conversion Cycle
|
85.29 | -73.82 | -15.02 | -13.03 | 5.38 |